2m 2m 2m 2m 2m 2m 2m
Instadose Pharma (INSD)
OTC
$0.000001$0.00 (0.00%)
Price as of Mar 25, 2026- N/AMarket Cap
- 0.00%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Instadose Pharma (INSD)
$0.000001$0.00 (0.00%)
Key Performance
More- Earnings Score: N/A
- Momentum Score: N/A
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
Insta and CHAOS Industries Partner to Counter Rising Aerial Threats in Europe
U.S. defense technology company CHAOS Industries and Finnish technology company Insta announced a partnership to integrate CHAOS's distributed sensing and radar capabilities into Insta's AirC2 command-and-control system. The collaboration aims to address unmanned aerial system threats in Finland and Northern Europe through cost-effective, layered air defense solutions, with a joint demonstration planned for Finland in the coming months.
07/02/2026, 1:03 AM • GlobeNewswire
Peers
Statistics
MoreDay Range
$0.000001
$0.000001
$0.000001
1-Year Range
$0.000001
$0.0001
$0.000001
Latest Close$0.000001
Change
$0.00 (0.00%)
Volume2,000
Information as of 03/25/2026
Company Profile
INSTADOSE PHARMA CORP
N/A
Market Cap
N/A
Net Income
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
INSTADOSE PHARMA CORP
Key Executives
- Lawrence Acton
- Loren S. Greenspoon
- Grant F. Sanders
- Antonio Franchino
Current Ownership Distribution
- Other531.9M (100.00%)
- Institutions0 (0.00%)
- Mutual Funds0 (0.00%)
- Insiders0 (0.00%)